Dawn E. Post
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Internal Medicine top 5%
Papers in
-
- Cancer Research and Treatments 5
- Genetics 9
- Virus-based gene therapy research 9
- Co-authors
- Erwin G. Van Meir (10 shared papers)Jonathan W. Simons (2 shared papers)Hua Zhong (2 shared papers)Daniel J. Brat (3 shared papers)Fadlo Raja Khuri (2 shared papers)Balveen Kaur (2 shared papers)Nicola J. Mabjeesh (1 shared paper)Margaret T. Willard (1 shared paper)
- Journals
- Gene Therapy (2 papers)Cancer Research (2 papers)Clinical Cancer Research (2 papers)Current Gene Therapy (1 paper)Cell Communication and Signaling (1 paper)
- Partner nations
- United StatesPolandHungary
In The Last Decade
Dawn E. Post
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 76
- Cancer Research 377
- Internal Medicine 73
- Genetics 508
- Biotechnology 132
- Oncology 324
Countries citing papers authored by Dawn E. Post
This map shows the geographic impact of Dawn E. Post's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Post with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Post more than expected).
Fields of papers citing papers by Dawn E. Post
This network shows the impact of papers produced by Dawn E. Post. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Post. The network helps show where Dawn E. Post may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn E. Post, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. | 2002 | 270 |
| 2 | 2005 | 207 | |
| 3 | 2004 | 138 | |
| 4 | 2003 | 115 | |
| 5 | 2004 | 96 | |
| 6 | 2007 | 95 | |
| 7 | 2016 | 66 | |
| 8 | 2003 | 63 | |
| 9 | 2004 | 53 | |
| 10 | 2004 | 52 | |
| 11 | 2013 | 40 | |
| 12 | 2019 | 34 | |
| 13 | 2010 | 26 | |
| 14 | 2017 | 17 | |
| 15 | 2010 | 15 | |
| 16 | 2005 | 13 | |
| 17 | 2011 | 9 | |
| 18 | 2026 | 1 |
About Dawn E. Post
Dawn E. Post is a scholar working on Biotechnology, Genetics, Cancer Research, Oncology and Molecular Biology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Cancer Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Heat shock proteins research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Cancer Research (377 citations), Internal Medicine (73 citations), Genetics (508 citations), Biotechnology (132 citations) and Oncology (324 citations). Dawn E. Post has collaborated with scholars based in United States, Poland and Hungary. Frequent co-authors include Erwin G. Van Meir, Jonathan W. Simons, Hua Zhong, Daniel J. Brat, Fadlo Raja Khuri, Balveen Kaur, Nicola J. Mabjeesh, Margaret T. Willard, Roland L. Chu and Russell O. Pieper. Their work appears in journals such as Gene Therapy, Cancer Research, Clinical Cancer Research, Current Gene Therapy and Cell Communication and Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.